CTRI/2021/09/036826
Suspended
Phase 2
A double blinded randomized controlled clinical study to evaluate the efficacy of the Tulasi Ashwagandhadi Herbal Drops on Oxygen Saturation (SPO2) in the management of COVID-19 affected cases.
Charak Hanf Pvt Ltd0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Sponsor
- Charak Hanf Pvt Ltd
- Status
- Suspended
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Male or female subjects who have been found to be COVID\-19 positive
- •The Oxygen Concentration level (SpO2\) is between 85\-95% observable during baseline screening.
- •Subjects in the age group 18\-65 years (both the ages inclusive).
- •Subjects willing to give a written informed consent and agree to come for a regular follow up visit.
- •Subjects with mild to moderate level of symptoms pertaining to COVID\-19
- •Subjects willing to abide by and comply with the study protocol.
- •Subjects who have not participated in a similar investigation in the past three months.
Exclusion Criteria
- •Subjects who have undergone invasive treatments like surgery or other treatment within 3 months before screening into the study.
- •Subjects having any active disease which may interfere in the study.
- •Any history of underlying uncontrolled medical illness including diabetes mellitus, hypertension, HIV, hepatitis, severe anemia, serious disorder of heart and respiratory apparatus or any other serious medical illness.
- •Subjects who have taken chemotherapy for cancer in the 6 months prior to start of the study or have a plan to do treatments during study.
- •Subjects (females) who are pregnant or lactating
- •A known history or present condition of allergic response/hypersensitivity to any ingredients and pharmaceutical products.
- •Chronic illness which may influence the respiratory state.
- •Subjects who had been part of any other clinical study within 3 months before screening into the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
The Comparison between two method of minisurgical percutaneous dilated tracheostomyThe relationship between two methods of small throat surgery through the skin.IRCT20150107020592N8Masih Daneshvari Hospital66
Completed
Not Applicable
evaluation of the ability of a drug (Tranexamic acid) in reducing blood loss during and after surgery in head and neck cancer patientsCTRI/2018/05/014184AIIMS86
Recruiting
Phase 4
Intratympanic Corticosteroid Therapy for Idiopathic Sudden Sensorineural Hearing LossIdiopathic Sudden Sensorineural Hearing LossEar - DeafnessACTRN12622001555741niversity of Melbourne200
Completed
Not Applicable
Randomized clinical trial of five adhesive systems in occlusal posterior restorationsISRCTN87835631niversity of Coimbra (Portugal)70
Not yet recruiting
Phase 2
A Clinical trial to study the effect of SDLSNT21 tablet in Patients of Nidranash(Insomnia).Health Condition 1: G470- InsomniaCTRI/2023/02/049355Dean Faculty of Ayurved